112018-01-6
112018-01-6
Chemical Structure
Bemoradan
- CAS No.: 112018-01-6
- Formula:C13H13N3O3
- Molecular Weight:259.26
IUPAC Name: 7-(4-methyl-6-oxo-1,4,5,6-tetrahydropyridazin-3-yl)-2H-benzo[b][1,4]oxazin-3(4H)-one
InChIKey: XZPGINPFWXLYNW-UHFFFAOYSA-N
SMILES: O=C1NN=C(C(C1)C)C2=CC3=C(NC(CO3)=O)C=C2
Biological Activity: Bemoradan (compound 10a) is an orally active and selective canine Phosphodiesterase (PDE) fraction III inhibitor. Bemoradan is a long-acting, potent, inotropic vasodilator and a novel cardiotonic agent, and can be used in congestive heart failure research[1].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Bemoradan | Bemoradan (compound 10a) is an orally active and selective canine Phosphodiesterase (PDE) fraction III inhibitor. Bemoradan is a long-acting, potent, inotropic vasodilator and a novel cardiotonic agent, and can be used in congestive heart failure research. | |||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
